Metabolic Research
Synthetic dual GIP / GLP-1 receptor agonist peptide supplied as a lyophilized powder for in-vitro incretin-signaling research.
CAS 2023788-19-2 · C225H348N48O68 · 4813.5 g/mol
For in-vitro research use only.
All products are for in-vitro laboratory research use only. Not for human or veterinary consumption.